CEPI provides $30m to advance novel coronavirus vaccine
European Pharmaceutical Review
JULY 11, 2022
These coronavirus RBDs are attached to a nanoparticle by protein tags, enabling the structure to display fragments from multiple viruses on a single nanoparticle. . 8 vaccine approach was supported by Wellcome Leap and Caltech’s Merkin Institute for Translational Research. . The innovative protein ?“glue” Ensuring access to vaccines.
95 
Let's personalize your content